Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3823_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
Figure 3.8 Stent position confirmation during
deployment.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Figure 3.9 Final result. Table 3.1 Major adverse events associated with
vertebral angioplasty.
Source: Data from Eberhardt et al. (2006); Jenkins et al. (2010).
Event Frequency (%)
TIA 1–2% Major stroke 1–2% MI 0% Death <1%
Importantly, extend the stent into the subclavian artery by 1–2 mm if stenting the proximal vertebral artery to assure complete coverage of the ostium. Ensure with fluoroscopy that the stent is well seated prior to deployment. The guidewire should always be kept within view during the procedure to prevent perforation and causing fatal intracranial hemorrhage. Care should be
exercised when using a hydrophilic guidewire. Multiple catheters, guidewires, balloons, and stents can be used in vertebral interventions not limited to those described in this guide (Table 3.1).
Management of Potential Complications
A team approach including a neurologist, neurointerventional radiologist, and a cardiologist is recommended to assist the interventionalist in dealing with any complications that may arise. Periprocedural complications of vertebral artery stenting include both adverse events associated with vertebral angioplasty as well as all other complications that accompany percutaneous procedures. Management of these complications requires repeat imaging to treat mechanical complications of the angioplasty procedure or catheter‐directed thrombolysis for thromboembolic events. The frequencies of these major adverse events are quite low (Table 3.2) [5, 8].
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Table 3.2 Interventional tools.
Source: Jenkins Vertebral artery interventions, Adapted from Schillinger and Minar (2010) [6].
Size Device
Guide catheter 6‐Fr Envoy
Judkins right Internal mammary Multipurpose
Guidewires 0.014
in.
Balance middle weight (Abbott) Wisper (Abbott) Choice PT (Cordis)
Embolic protection 4–6
mm
Filterwire (BSC)
Stents balloon expandable
3–6 mm
Vision (Abbott) RX Herculink Elite (Abbott) Express renal/biliary SD (BSC) Multi‐link ultra coronary stent (Cordis)
Stents self‐ expanding
4–7 mm
Xpert pro peripheral stent (Abbott)
Postprocedural Care
1. Plavix (75 mg daily) should be continued for one month after the procedure if bare‐metal stents are used with aspirin (81 mg daily) to be continued indefinitely. If drug‐eluting stents are used, dual antiplatelet therapy should be continued six months to one year.
2. Dual antiplatelet therapy is frequently continued indefinitely with the use of drug‐eluting stents to prevent the occurrence of late stent thrombosis.
3. Duplex ultrasound should be performed at 3, 6, and 12 months and yearly thereafter, if VBI symptoms resolve. Patients with recurrent symptoms should
undergo repeat angiography to identify restenosis or progression of atherosclerotic disease.
References
1 Markus, H.S., Larsson, S.C., Kuker, S.C. et al. (2018).
Stenting for symptomatic vertebral artery stenosis: the vertebral artery ischaemia stenting trial. J. Vasc. Surg. 67 (3): 986.
2 Markus, H.S., Larsson, S.C., Kuker, W. et al. (2017 Sep
19). Stenting for symptomatic vertebral artery stenosis. Neurology 89 (12): 1229.
3 (2001). Endovascular versus surgical treatment in
patients with carotid stenosis in the carotid and vertebral artery transluminal angioplasty study (CAVATAS): a randomised trial. The Lancet 357 (9270): 1729–1737.
4 Jenkins, J.S. (2014). Percutaneous treatment of
vertebral artery stenosis. Interv. Cardiol. Clin. 3 (1): 115–122.
5 Jenkins, J.S., Patel, S.N., White, C.J. et al. (2010).
Endovascular stenting for vertebral artery stenosis. J. Am. Coll. Cardiol. 55 (6): 538–542.
6 Schillinger, M. and Minar, E. (2010). Complex Cases in
Peripheral Vascular Interventions, 308. CRC Press.
7 Garry, B.P. and Bivens, H.E. (1988). The Seldinger
technique. J. Cardiothorac. Anesth. 2 (3): 403.
8 Eberhardt, O., Naegele, T., Raygrotzki, S. et al. (2006).
Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J. Vasc. Surg. 43 (6): 1145–1154.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
4 Endovascular Repair of Thoracic Aortic Aneurysms: Catheter‐Based
Therapy
John Denesopolis, Patricia Yau, and Aksim G. Rivera
Department of Surgery (Vascular Surgery), Albert Einstein College of Medicine-Jacobi Medical Center, Bronx, NY, USA
Introduction
Thoracic aortic pathology has increasingly become a major cause of mortality in the United States, accounting for at least 13 000 deaths annually, with incidence 5.6–
10.4 cases per 100 000 people. Thoracic aortic aneurysm (TAA) is predominantly a disease of the older people, with risk factors similar to that of patients with abdominal aortic aneurysm (AAA), i.e. smoking, hypertension, and atherosclerotic disease. The majority are degenerative in etiology, though approximately 20% are sequelae of chronic aortic dissection. Most diagnosed thoracic aortic and thoracoabdominal aortic aneurysms (TAAA) are not symptomatic, and are incidentally noted on imaging obtained for unrelated reasons [1].
The use of endovascular stent grafting, first popularized for AAAs, has now become a mainstay of treatment for TAA. Thoracic endovascular aortic repair (TEVAR) has been shown to have clear benefit in morbidity and mortality to open repair in more recent literature. In patients with less‐than‐ideal anatomy, e.g. involvement of major aortic branches, tortuous anatomy, large diameter neck, etc., the advantage of endovascular repair over open repair becomes less pronounced. However, with more sophisticated technology, as well as the advent of fenestrated, branching, and hybrid techniques, the use
of TEVAR in patients with complex aortic pathology has proven to be safe, effective, and durable. Additionally, the indications for use of TEVAR have expanded to include blunt traumatic aortic injury, aortic dissection, and acute aortic syndromes.
Relevant Anatomy
Aortic Anatomy
The thoracic aorta consists of four main parts: the aortic root, the ascending thoracic aorta, the aortic arch, and the descending thoracic aorta. The aorta normally enlarges as it progresses distally, and moves posterolaterally in the proximal portion, and anteromedially closer to the diaphragm. Aneurysmal dilatation is defined as 1.5 × normal diameter; normal diameter for the descending aorta is 2.0–2.3 cm. Aneurysm morphology is characterized as fusiform or saccular, with saccular aneurysms having a higher risk of rupture.
Crawford Classification for TAA/TAAA
Type I: arises from above 6th intercostal space, extends to above the renal arteries
Type II: arises above 6th intercostal space, extends distal to the renal arteries
Type III: arises in the distal half of the descending thoracic aorta (below the 6th intercostal space), extends into the abdominal aorta
Type IV: limited to abdominal aorta (diaphragm to aortic bifurcation)
Type V: distal half of descending thoracic aorta to visceral abdominal aorta
Landing Zones (Figure 4.1)
Zone 0: proximal to innominate artery
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Zone 1: proximal to CCA Zone 2: proximal to origin of left SCA Zone 3: proximal descending aorta (<2 cm from left
SCA) Zone 4: 2 cm distal to SCA, to proximal half of
descending thoracic aorta (T6) Zone 5: distal half descending thoracic aorta to
celiac artery Zone 6: celiac to SMA Zone 7: SMA to suprarenal aorta Zone 8: perirenal aorta Zone 9: infrarenal aorta Zone 10: common iliac arteries Zone 11: external iliac arteries
Figure 4.1 Aortic landing ones.
Preoperative planning for TEVAR requires consideration of proximal and distal landing zones and the potential
for coverage of major aortic branches. At least 20 mm of proximal and distal landing zone is recommended to allow adequate seal. If there is significant tortuosity, a longer sealing zone may be desired.
Consideration of aortoiliac anatomy is important for determining arterial access and potential need for iliac conduit for graft delivery. The right iliac artery is the preferred route of graft delivery. The access vessel should be at least 7 mm in diameter. If there is not an adequately sized vessel, or if there is significant atherosclerotic disease, an iliac conduit may be required for device delivery. In rare cases where the entire iliac system is diseased, direct aortic access or an iliac endoconduit may be used (described below).
Implication of Aortic Anatomy on Spinal Perfusion
Spinal cord ischemia is a particularly devastating complication that may occur in 3–7% of patients following TEVAR. Rates of spinal cord ischemia have remained the same despite increasing use of endovascular repair. The blood supply to the spinal cord consists of the posterior spinal arteries (arising from the vertebral or posterior inferior cerebellar arteries), anterior spinal artery (originates from the vertebral arteries), and supported by the artery of Adamkiewicz (usually takes off between T8 and L2). This network is reinforced by collaterals from the radicular arteries, which are supplied by inflow vessels: subclavian/vertebrals, thyrocervical and costocervical trunks, intercostals, lumbar arteries, and branches of hypogastric. Thus, the risk of spinal cord ischemia is increased with coverage of the left SCA and coverage of the hypogastric. Increased length of aortic coverage, renal insufficiency, prior abdominal aortic repair, and intraoperative hypotension are other risk factors for spinal cord ischemia. Coverage of the left SCA also significantly increases the risk of stroke, particularly in 60% of patients with a dominant left vertebral artery. Revascularization of the left SCA, usually by carotid to subclavian bypass, is mandatory in these patients if the left SCA is covered. If surgical reconstruction is
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
contraindicated and left SCA coverage is anticipated, preoperative evaluation should include imaging to assess patency of the right vertebral artery and continuity of the circle of Willis.
Indications/Contraindications to Procedure
Indications
Asymptomatic TAA/TAAA
The goal of surgical intervention for asymptomatic TAA/TAAA is the prevention of rupture. The most important risk factors for rupture for TAAs are size, rate of expansion, and saccular morphology. Current criteria for elective repair of asymptomatic TAA are maximum diameter >5.5 or growth >5 mm over six months [2].
Blunt Aortic Injury (BAI)
TEVAR has largely replaced open repair as first‐line surgical management for BAI. Traditionally, the goal has been for definitive surgical repair as early as possible; however, recent data has shown decreased risk of mortality in delayed (>24 hours) repair.
Acute Aortic Syndromes
Type B aortic dissection (TBAD): First‐line treatment for uncomplicated TBAD continues to be medical management with tight blood pressure control. However, TBAD with malperfusion may be treated with TEVAR with the goal of sealing the proximal tear and allowing reexpansion of the true lumen [3, 4]. Between 40 and 60% of TBAD which are treated with medical management undergo aneurysmal degeneration of the false lumen, requiring surgical intervention. There may be a role for elective TEVAR in the subacute period. The INSTEAD trial investigated treatment of subacute TBAD, comparing those treated with endograft and medical management. The data revealed that there was no